MMP9 and amyotrophic lateral sclerosis: Using the Fluorokine E assay, the level of MMP-9 activity was measured within a serum sample from ALS, performed in parallel with a series of identical serum samples spiked with varying concentrations of the inhibitor AQU-118, to see if one could observe any differences in protease activity between those with and without the spiked inhibitor.